Home > Financial Ratios > CORAL LABORATORIES

CORAL LABORATORIES
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

CORAL LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 54.55113.62-17.82-33.6073.39

What is the latest Core EBITDA Growth ratio of CORAL LABORATORIES ?

The latest Core EBITDA Growth ratio of CORAL LABORATORIES is 54.55 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202554.55
Mar2024113.62
Mar2023-17.82
Mar2022-33.60
Mar202173.39

How is Core EBITDA Growth of CORAL LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 54.55
-51.99
Mar2024 113.62
Positive
Mar2023 -17.82
Negative
Mar2022 -33.6
Negative
Mar2021 73.39 -

Other Financial Ratios of CORAL LABORATORIES


Compare Core EBITDA Growth ratio of peers of CORAL LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORAL LABORATORIES ₹164.2 Cr 5.4% -0.1% -38.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,559.0 Cr 7.1% -1.5% -6.2% Stock Analytics
DIVIS LABORATORIES ₹164,827.0 Cr 2.8% -2.8% 6% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,942.0 Cr 3.1% 4.2% 18.8% Stock Analytics
CIPLA ₹106,825.0 Cr 0.2% -12.5% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,077.0 Cr 2.2% -1.6% 0% Stock Analytics


CORAL LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORAL LABORATORIES

5.4%

-0.1%

-38.3%

SENSEX

1.7%

-1.7%

10.3%


You may also like the below Video Courses